Search results with tag "Treatment regimens"
Latent Tuberculosis Treatment Regimens
www.cdc.govTreatment Regimens Treatment regimens for latent TB infection (LTBI) use isoniazid (INH), rifapentine (RPT), or rifampin (RIF). CDC and the National Tuberculosis Controllers Association preferentially recommend short-course, rifamycin-based, 3- or 4-month latent TB infection treatment regimens over 6- or 9-month isoniazid monotherapy.
·Multiple Myeloma: Diagnosis and Treatment
www.panoramaortho.comThe diagnosis and treatment of multiple myeloma has changed dramatically in the past <lecade. The ... number of treatment regimens available for patients in all stages of the disease. DIAGNOSIS The most common presenting symptoms of MM are fatigue and bone pain.6 Anemia occurs in
Understanding Multiple Myeloma, Its Treatment, and New ...
www.ashpadvantagemedia.comEvaluate treatment regimens for patients with relapsed, refractory multiple myeloma. Illustrate strategies for addressing the supportive care needs of patients with multiple myeloma who experience adverse reactions or develop complications.
Case Studies: Evolving Paradigms in Myeloma Care
imf-ons.myeloma.org•Identify common treatment regimens in newly diagnosed and relapsed multiple myeloma •Apply best practices in management of MM patients receiving myeloma therapeutic regimens, including effective symptom management ... Multiple Myeloma Typically Preceded by Premalignant Conditions 10 Premalignant Malignant
Multiple Myeloma - Alberta Health Services
www.albertahealthservices.caTREATMENT REGIMENS FOR MULTIPLE MYELOMA 57 . Page 3 of 62 . CLINICAL PRACTICE GUIDELINE LYHE-003 . Page 4 of 62 . CLINICAL PRACTICE GUIDELINE LYHE-003 . BACKGROUND. Multiple myeloma (MM) is an aggressive malignant neoplasm of plasma cells that accumulates in the bone
Treatment Regimens and Duration of Lines of Therapy in ...
www.cdrg.orgTreatment Regimens and Duration of Lines of Therapy in Medicare-Enrolled Patients With Multiple Myeloma ... • Duration of treatment regimens is shown in Table 3. – Overall, the mean duration of line of therapies 1 through 4 was 386, 329, 268, and 232 days,